Adult obesity rate fell from record high—and big pharma is reaping the benefits from mainstream sales of weight-loss drugs like Zepound and Mounjaro

Eli Lilly has announced that its new weight-loss pill is a strong candidate for expedited approval under a recent U.S. program aimed at fast-tracking innovative treatments. This is significant as it could provide a much-needed solution for obesity, a growing health concern in the U.S. The potential quick approval could mean that many individuals struggling with weight management may soon have access to effective medication, highlighting the importance of innovation in healthcare.

Eli Lilly has reported earnings that exceeded expectations by $1.13, along with revenue that topped estimates. This strong financial performance highlights the company's robust growth and effective strategies in the pharmaceutical market, which is crucial for investors and stakeholders looking for stability and potential in their investments.

Eli Lilly has raised its annual revenue guidance, reflecting the strong demand for its weight-loss drug. This increase is significant as it highlights the growing market for obesity treatments and the company's ability to capitalize on this trend. Investors and stakeholders are optimistic about the potential for continued growth, making this a noteworthy development in the pharmaceutical industry.

Eli Lilly has announced a significant investment of $1.2 billion in Puerto Rico, marking a major step in the company's commitment to expanding its manufacturing capabilities in the United States. This investment is expected to create thousands of jobs and boost the local economy, highlighting the importance of domestic production in the pharmaceutical industry. As companies like Eli Lilly focus on strengthening their supply chains, this move not only benefits the company but also supports the broader economic landscape in Puerto Rico.

Cris Sholto Heaton discusses the uncertain future of artificial intelligence, emphasizing that while its potential to revolutionize the world is still unclear, the consequences of failing to embrace it could be significant. This conversation is crucial as it highlights the importance of adapting to technological advancements and the risks of inaction.

The US is set to announce that Nexperia's facilities in China will resume shipments, a move that is expected to boost the semiconductor supply chain. This decision is significant as it reflects a potential easing of trade tensions and could help stabilize the market, which has faced disruptions in recent months. By allowing Nexperia to continue operations, it not only supports the company but also contributes to the broader tech industry, which relies heavily on these components.

Qualcomm has reported a 10% increase in revenue for Q3 FY25, driven by significant growth in its automotive and IoT segments. This surge highlights the company's successful adaptation to market demands and its strategic focus on emerging technologies, which are becoming increasingly vital in today's digital landscape. As the automotive industry shifts towards more connected and automated solutions, Qualcomm's advancements position it well for future opportunities.

Qualcomm's Q3 2025 earnings call revealed impressive revenue growth, leading to a rise in its stock price. This positive financial performance highlights the company's strong market position and effective strategies, which are crucial for investors and stakeholders looking for stability and growth in the tech sector.

A new technique in prompt engineering called verbalized sampling is making waves in the AI community. This innovative approach encourages generative AI to think more freely, moving beyond just providing the top-ranked answers. By guiding users through this process, it enhances the quality of responses, making interactions with AI more meaningful and effective. This development is significant as it opens up new possibilities for how we engage with AI technology, potentially leading to richer and more nuanced conversations.

Hastings, located in East Sussex, has been identified as one of the most deprived towns in England, highlighting significant social and economic challenges faced by its residents. This situation matters because it sheds light on the broader issues of inequality and the need for targeted support and resources to improve living conditions and opportunities for the community.